Common Chemotherapeutic Acronyms
| Abbreviation | Use | Regimen | Frequency |
| ABDIC | Hodgkins (MOPP resistant) |
Doxorubicin Bleomycin |
Every 4 weeks |
| ABVD | Hodgkins (MOPP resistant) |
Doxorubicin Bleomycin Vinblastine Dacarbazine |
Twice monthly until remission, then 2 more cycles |
| ACE | Small cell lung ca | Doxorubicin Cyclophosphamide Etoposide |
Every 3 weeks |
| ACe | Metastatic or recurrent breast ca and ovarian ca | Doxorubicin Cyclophosphamide |
Every 3-4 weeks |
| AP | Advanced ovarian ca | Doxorubicin Cisplatin |
Every 3 weeks |
| A-COPP | Hodgkins | Doxorubicin Cyclophosphamide Vincristine Procarbazine Prednisone |
Every 6 weeks for 6 cycles |
| ADR+BCNU | Alkylator resistant Multiple Myeloma | Doxorubicin Carmustine |
Every 3-4weeks |
| ARA-C+ADR | AML | Cytarabine Doxorubicin |
Every 2-4 weeks |
| ARA-C+ADR+VCR+ Prednisone | AML | Cytarabine Doxorubicin Vincristine Prednisone |
Every 2-4 weeks |
| ARA-C+6-TG | AML | Cytarabine Thioguanine |
Every month until remission |
| ARA-C+6-TG+DNR | AML | Cytarabine Thioguanine Daunorubicin |
Every 2-4 weeks |
| ARA-C+DNR | ALL | Cytarabine Daunorubicin |
Every 2-4 weeks |
| ARA-C+DNR+6-TG +VCR+Pred |
ALL | Cytarabine Daunorubicin Thioguanine Vincristine Prednisone |
Every 2-4 weeks |
| ARA-C+DNR+MP+ Pred |
AML | Cytarabine Daunorubicin Mercaptopurine Prednisone |
Every week until remission |
| BACOP | Non-Hodgkins | Bleomycin Doxorubicin Cyclophosphamide Vincristine Prednisone |
Every 4 weeks |
| B-CAVe | Advanced Hodgkins | Bleomycin CCNU Doxorubicin Vinblastine |
|
| BCVPP | Hodgkins | Carmustine Cyclophosphamide Vinblastine Procarbazine Prednisone |
Every 4 weeks |
| CAF | Metastatic breast ca | Cyclophosphamide Doxorubicin Flourouracil |
Every 4 weeks until doxorubicin is therapeutic then add methotrexate |
| CAMP | Non-Small lung ca | Cyclophosphamide Doxorubicin Methotrexate Procarbazine |
Every 4 weeks |
| CAP | Non-Small lung ca and advanced ovarian ca | Cyclophosphamide Doxorubicin Cisplatin |
Every 4 weeks |
| CAV | Small cell lung ca | Cyclophosphamide Doxorubicin Vincristine |
Every 3 weeks |
| CAVe | Hodgkins resistant to MOPP | Lomustine Doxorubicin Vinblastin |
Every 6 weeks |
| CHL+Pred | CLL | Chlorambucil Prednisone |
Every other week |
| CHOP | Non Hodgkins | Cyclophosphamide Doxorubicin Vincristine Prednisone |
Every 3-4 weeks |
| CHOR | Small cell lung ca | Cyclophosphamide Doxorubicin Vincristine Prednisone |
Every 3-4 weeks |
| CISCA | Urinary tract metastatic | Cyclophosphamide Doxorubicin Cispltatin |
Every 3 weeks |
| CISCA-II/VB-IV | Germ Cell tumors | Cyclophosphamide Doxorubicin Cisplatin Vinblastine Bleomycin |
Every 3-4 weeks |
| CMC | Small cell lung ca | Cyclophosphamide Methotrexate Lomustine |
One cycle only |
| CMF | Metastatic or recurrent breast ca | Cyclophosphamide Methotrexate Flourouracil |
Every 3-4 weeks |
| CMFP | Metastatic breast ca | Cyclophosphamide Methotrexate Flourouracil Prednisone |
Every 4 weeks |
| CMFVP(Coopers Regimen) | Metastatic or recurrent breast ca | Cyclophosphamide Methotrexatre Flourouracil Vincristine, Prednisone |
Every week for eight weeks |
| COMLA | Non-hodgkins | Cyclophosphamide Vincristine Cytarabine Methotrexate Leucovorin |
Every 12 weeks |
| COP | Non-hodgkins | Cyclophosphamide Vincristine Prednisone |
Every 3 weeks |
| COP-BLAM | Non-hodgkins | Cyclophosphamide Vincristine Prednisone Bleomycin Doxorubicin Procarbazine |
Every 3 weeks |
| COPP | Non-hodgkins | Cyclophosphamide Vincristine Procarbazine Prednisone |
Every 4 weeks |
| CVP | Non-hodgkins | Cyclophosphamide Vincristine |
Every 3 weeks |
| CVAD | Soft tissue sarcomas | Cylophosphamide Doxorubicin Dacarbazine |
Every 3 weeks |
| FAC | Breast ca | Flourouracil Doxorubicin Cyclophosphamide |
Every 3 weeks |
| FAM | Non small lung ca | Flourouracil Doxorubicin mitomycin |
Every 8 weeks |
| FOMi | Non small cell lung ca | Flourouracil Vincristine Mitomycin |
Every 3 weeks |
| M-2 Protocol | Multiple Myeloma | Vincristine Carmustine Cyclophosphamide Melphalan Prednisone |
Every 3-4 weeks |
| MAC | Advanced ovarian ca | Mitomycin Doxorubicin Cyclophosphamide |
Every 3 weeks |
| MACC | Non small lung ca | Methotrexate Doxorubicin Cyclophosphamide Lomustine |
Every 3 weeks |
| MAP | Multiple Myeloma | Melphalan Doxorubicin Prednisone |
Every 4 weeks |
| MOPP | Hodgkins | Mechlorethamine Vincristine Procarbazine Prednisone |
Every 4 weeks |
| MOPP/ABVD | Advanced Hodgkins | Mechlorethamine Vincristine Procarbazine Prednisone |
Every other
month Continued next page |
| MOPP/ABVD continued | Alternate
with Doxorubicin Bleomycin Vinblastine Dacarbazine |
Every other month | |
| MOPP-LO BLEO |
Hodgkins | Mechloroethamine Vincristine Procarbazine Prednisone Bleomycin |
Every 4 weeks |
| MPL+Pred | Multiple Myeloma | Melphalan Prednisone |
Every 4 weeks |
| MTX + MP | ALL | Methotrexate Mercaptopurine |
|
| MTX+MP+CTX | ALL | Methotrexate Mercaptopurine Cyclophosphamide |
|
| M-VAC | Transitional cell bladder cancer | Methotrexate Vinblastine Doxorubicin Cisplatin |
Every 4 weeks |
| MV1b | Metastatic or recurrent breast cancer | Mitomycin Vinblastine Procarbazine |
Every 6-8 weeks |
| POCC | Small cell lung ca | Procarbazine Vincristine Cyclophosphamide Lomustine |
Every 4 weeks |
| PVB | Testicular ca | Cisplatin Vinblastine Bleomycin |
Every 3 weeks |
| VAB-6 | Testicular ca | Cyclophosphamide Dactinomycin Vinblastine Bleomycin Cisplatin |
Every 3-4 weeks x2 |
| VAC | Soft tissue sarcomas (rhabdomyosarcoma) | Vincristine Dactinomycin Cyclophosphamide |
Every 3 months |
| VAD | Refractory multiple myeloma | Vincrstine Doxorubicin Cyclophoposphamide |
Every 25 days |
| VBAP | Multiple myeloma | Vincristine Carmustine Doxorubicin Prednisone |
Every 3 weeks |
| VBP | Disseminated testicular ca | Vinblastine Cisplatin Bleomycin |
Every 4 weeks |
| VMCP | Multiple myeloma | Vincristine Melphalan Cyclophosphamide |
Every 3 weeks |
| VP | ALL | Vincristine Prednisone |
One cycle only |